Vincenzo Ezio Santobuono | Cardiovascular Disease | Innovative Research Award

Published on by Global Academic Awards

Prof. Vincenzo Ezio Santobuono | Cardiovascular Disease | Innovative Research Award

University of Bari Aldo Moro | Italy

Prof. Vincenzo Ezio Santobuono is an accomplished cardiologist and academic with a Classical High School Diploma (1999), a Degree in Medicine and Surgery from the University of Bari (2006, summa cum laude), a Specialization in Cardiology (2011, summa cum laude), and a PhD in Experimental and Forensic Medicine and Pathology (2015). He has built a distinguished career combining clinical expertise, academic leadership, and pioneering research in cardiology, particularly in telecardiology, remote monitoring, arrhythmia management, and cardiac resynchronization therapy. Professionally, he has served as Medical Director at the Regional TeleCardiology Center of Bari, specialist consultant for military and governmental institutions, and lecturer at the University of Bari “Aldo Moro” across nursing, medicine, radiology, psychiatric rehabilitation, and cardiovascular disease programs. Currently, he is a fixed-term researcher (RTD-A) leading an innovative project on telecardiology integration within hospital-territory networks. His academic impact is reflected in Scopus metrics with 502 citations, 52 indexed documents, and an h-index of 11, alongside numerous high-impact publications and a patent on supraventricular arrhythmia treatment. Fluent in English and Italian, he actively contributes to cardiovascular innovation, bridging advanced clinical practice with technological solutions to improve patient-centered care and healthcare delivery.

Profile: Scopus | Orcid

Featured Publications

  • Santobuono, V. E., et al. (2025). NPPA-associated atrial dilated cardiomyopathy: Genotypic and phenotypic insights from an ultrarare inherited disorder.

  • Santobuono, V. E., et al. (2025). Differentiating sensor changes in a composite heart failure ICD monitoring index: Clinical correlates and implications.

  • Santobuono, V. E., et al. (2025). Association between device-detected subclinical atrial fibrillation and diabetes in patients with implantable cardioverter-defibrillators: A propensity score-matched analysis. International Journal of Cardiology.

  • Santobuono, V. E., et al. (2025). Kinetics of procalcitonin, CRP, IL-6, and presepsin in heart transplant patients undergoing induction with thymoglobulin (rATG). Journal of Clinical Medicine.

  • Santobuono, V. E., et al. (2025). Dynamic evaluation of atrial fibrillation risk factors using multiple sensors of implantable cardioverter defibrillators.

Shixun Wang | Cardiology | Best Researcher Award

Published on by Global Academic Awards

Dr. Shixun Wang | Cardiology | Best Researcher Award

Professor at Weifang People’s Hospital, China

Dr. Wang Shixun 👨‍⚕️, born in October 1979, is a distinguished cardiovascular specialist at Weifang People’s Hospital. He earned his doctorate in Cardiovascular Medicine from Weifang Medical College in 2006 and has over 18 years of clinical experience. Currently serving as Deputy Director, he is applying for the position of Chief Physician 👨‍🔬. Known for his excellence in clinical practice, he received top evaluation ratings from 2018 to 2021 🌟. Dr. Wang demonstrates strong computer and foreign language skills 💻🗣️ and is highly respected for his dedication to cardiovascular care and hospital leadership ❤️🏥.

Publication Profile

Scopus

Orcid

Academic Background

Dr. Wang Shixun 👨‍⚕️ graduated from Weifang Medical College in July 2006 🎓, earning his doctorate in Cardiovascular Medicine ❤️. Immediately after graduation, he began his medical career at Weifang People’s Hospital 🏥, demonstrating a seamless transition from academic training to clinical practice. With a strong foundation in medical education and a passion for patient care 💉, Dr. Wang quickly established himself as a dedicated healthcare professional. His long-term commitment to the same institution reflects both loyalty and deep institutional knowledge 📘, making him a valuable asset to the hospital and the broader medical community 🌟.

Professional Experience

Dr. Wang Shixun 👨‍⚕️ obtained his current professional and technical qualifications in March 2017 and has since shown remarkable growth in the field of Cardiovascular Medicine ❤️. He was first appointed to his current role in September 2018 and has accumulated five years of dedicated service in this position. Dr. Wang now applies for the title of Chief Physician, reflecting his advanced clinical expertise and leadership readiness 🧠. He also serves as Deputy Director 🏥, balancing administrative responsibilities with medical duties. Additionally, he has demonstrated proficiency in computer applications 💻, enhancing his effectiveness in modern healthcare delivery.

Awards and Honors

Dr. Wang Shixun 👨‍⚕️ has consistently demonstrated excellence in his medical career, earning outstanding performance evaluations for four consecutive years—2018, 2019, 2020, and 2021 🏅. These “Excellent” ratings reflect his dedication, clinical skill, and strong work ethic in the field of Cardiovascular Medicine ❤️. In 2022, he continued to maintain a high standard with a “Qualified” rating ✅. His consistent recognition by peers and superiors underscores his commitment to medical excellence and patient care 🙌. These honors highlight Dr. Wang’s growing influence and leadership within the hospital and the broader medical community 🏥✨.

Research Focus

Dr. Wang Shixun 👨‍⚕️ is deeply engaged in the field of Cardiovascular Medicine, with a strong focus on clinical research aimed at improving patient outcomes and advancing treatment strategies for heart-related conditions ❤️🫀. His work emphasizes evidence-based practices, integrating the latest medical advancements into routine care 🧬📊. As Deputy Director at Weifang People’s Hospital 🏥, he actively participates in research initiatives and fosters a collaborative environment for innovation and knowledge sharing 🤝💡. With his solid academic foundation and practical experience, Dr. Wang continues to explore new frontiers in cardiovascular healthcare to benefit patients and the medical community 🌍📚.

Publication Top Notes

📝 A Case of Treatment With a Combination of Covered Stents and Artificial Blood Vessel for Iliac Artery Rupture During Transcatheter Aortic Valve Replacement

📅 Year: 2025 | 📚 Journal: Clinical Case Reports

Efficacy and Safety of Different Dosing Regimens of Colchicine in Patients with Coronary Artery Disease: A Network Meta-analysis of 15 Randomized Controlled Trials

Effect of levocarnitine on TIMP-1, ICAM-1 expression of rats with coronary heart disease and its myocardial protection effect

Serum Amyloid a Promotes Visfatin Expression in Macrophages

Plumbagin mediates cardioprotection against myocardial ischemia/reperfusion injury through Nrf-2 signaling

Conclusion

Dr. Wang Shixun is a highly skilled and experienced medical professional in the field of Cardiovascular Medicine, currently serving as Deputy Director at Weifang People’s Hospital and applying for the position of Chief Physician. With a doctoral degree and nearly two decades of clinical service since 2006, he has consistently demonstrated excellence, as reflected in multiple years of outstanding evaluations. He also shows proficiency in foreign languages and computer applications. However, while his clinical credentials and leadership are commendable, there is currently limited evidence of significant research contributions—such as peer-reviewed publications, funded projects, or academic impact—needed to support a strong case for a Best Researcher Award.

Anna Truong | Cardiology | Best Researcher Award

Published on by Global Academic Awards

Ms. Anna Truong | Cardiology | Best Researcher Award

Pharmacist at Monash health, Australia

Anna Truong is a dedicated clinical pharmacist with extensive experience in cardiology, geriatrics, and intensive care 🫀💊. She holds a Master of Clinical Pharmacy and multiple postgraduate certificates from Monash University 🎓. Currently serving at the Victorian Heart Hospital, Anna actively contributes to patient care, clinical education, and multidisciplinary collaboration. Her roles have included research on medication titration for heart failure and involvement in the Virtual Hospital project. Known for her proactive and compassionate approach, she is committed to quality improvement and mentoring future pharmacists 🌟. Outside of work, she enjoys yoga, painting, and travelling 🧘‍♀️🎨✈️.

Publication Profile

Orcid

Academic Background

Anna Truong has a strong academic background in pharmacy and medicinal chemistry. She earned her Bachelor of Medicinal Chemistry, focusing on drug design and discovery, from Monash University Clayton/Parkville between 2006 and 2008 💊🔬. She then completed her Bachelor of Pharmacy with Honours at Monash University Parkville from 2009 to 2012. Further advancing her expertise, Anna attained graduate certificates in Geriatrics and Mental Health during 2015-2016 🧠👵. Most recently, she completed a Master of Clinical Pharmacy from Monash University Parkville between 2018 and 2020, solidifying her clinical knowledge and skills to excel in patient care and research.

Professional Experience

Anna Truong is a dedicated pharmacist with diverse clinical experience across multiple health settings. Since March 2023, she has worked as a rotational pharmacist at the Victorian Heart Hospital, actively participating in cardiology ward rounds and educating new pharmacists and students 🏥❤️. From 2019 to 2023, she served at Monash Health Clayton, covering cardiology, intensive care, neurosurgery, and surgical areas, contributing to clinical projects and mentoring students 🏨📋. Earlier roles include clinical pharmacist positions at Peninsula Health Frankston and Middlemore Hospital Auckland, where she supported geriatric and orthopaedic care, supervised pharmacy training, and enhanced medication safety 🧓🔬. Her early career included locum pharmacist and intern roles, providing patient-focused medication management across diverse clinical areas.

Awards and Honors

Anna Truong has been recognized for her dedication and excellence in clinical pharmacy. Throughout her career, she has received commendations for her leadership in cardiology pharmacy services and contributions to quality improvement projects 💊👏. Her commitment to education and mentorship has earned her appreciation from both colleagues and students 🎓🤝. Anna’s proactive approach in optimizing medication safety and patient care has been acknowledged in hospital award programs and pharmacy professional bodies 🏥🎖️. These honors reflect her passion for advancing pharmacy practice and delivering exceptional healthcare outcomes.

Research Focus

Anna Truong brings extensive clinical expertise across Cardiology, Intensive Care, Neurosurgery, Surgery, General Medicine, and Geriatrics. She is deeply motivated to continuously learn and contribute to educating pharmacists, students, and interns, fostering exceptional patient care, especially in Cardiology 🫀📚. With excellent interpersonal and teamwork skills, she thrives in multidisciplinary environments, building strong professional relationships and mentoring future pharmacy professionals 🤝👩‍⚕️. Anna approaches her work with reliability, energy, and a proactive mindset focused on quality improvement. She adapts swiftly to fast-paced settings and excels in time management and organization, ensuring deadlines and patient needs are met efficiently ⏱️⚡.

Publication Top Notes

The impact of a transition of care electronic medication titration plan on optimising the treatment of heart failure after hospital discharge 🫀💊
Year: 2025 | Contributors: Anna Truong, Adeline Roussety 📄✨

Conclusion

Anna Truong is an outstanding candidate for a “Best Researcher Award” due to her leadership in clinically impactful research on electronic medication titration for heart failure, strong collaboration with multidisciplinary teams at Monash Heart, and active involvement in innovative projects like the Virtual Hospital and atrial fibrillation chatbot. Her extensive clinical experience across Cardiology, ICU, Geriatrics, and General Medicine, combined with her contributions to guideline development, education, and mentoring, demonstrate a deep commitment to advancing pharmacy practice. Coupled with her active role in quality improvement committees and professional credentials, Anna exemplifies excellence in clinical research and evidence-based care implementation.